1	The	The	B-NP	DT	O	2	NMOD	0
2	effects	effect	I-NP	NNS	O	0	ROOT	16	effects
3	of	of	B-PP	IN	O	2	NMOD	0
4	radiation	radiation	B-NP	NN	O	3	PMOD	0
5	on	on	B-PP	IN	O	2	NMOD	0
6	neovascularization	neovascularization	B-NP	NN	O	5	PMOD	3	neovascularization
7	in	in	B-PP	IN	O	2	NMOD	0
8	a	a	B-NP	DT	O	10	NMOD	0
9	rat	rat	I-NP	NN	O	10	NMOD	0
10	model	model	I-NP	NN	O	7	PMOD	0
11	.	.	O	.	O	2	P	0

1	It	It	B-NP	PRP	O	2	SUB	0
2	is	be	B-VP	VBZ	O	17	VMOD	0
3	thought	think	I-VP	VBN	O	2	VC	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	radiation	radiation	B-NP	NN	O	6	NMOD	0
6	treatment	treatment	I-NP	NN	O	7	SUB	0
7	inhibits	inhibit	B-VP	VBZ	O	4	SBAR	18	inhibits
8	neovascularization	neovascularization	B-NP	NN	O	7	OBJ	3	neovascularization
9	of	of	B-PP	IN	O	8	NMOD	0
10	recipient	recipient	B-NP	NN	O	13	NMOD	0
11	and/or	and/or	I-NP	CC	O	13	NMOD	0
12	graft	graft	I-NP	NN	O	13	NMOD	0
13	tissues	tissue	I-NP	NNS	O	9	PMOD	0
14	,	,	O	,	O	17	P	0
15	and	and	O	CC	O	17	VMOD	0
16	this	this	B-NP	DT	O	17	SUB	0
17	may	may	B-VP	MD	O	0	ROOT	0
18	account	account	I-VP	VB	O	17	VC	0
19	in	in	B-PP	IN	O	18	VMOD	0
20	part	part	B-NP	NN	O	19	PMOD	0
21	for	for	B-PP	IN	O	19	PMOD	0
22	abnormalities	abnormality	B-NP	NNS	O	21	PMOD	0
23	in	in	B-PP	IN	O	22	NMOD	0
24	wound	wound	B-NP	NN	O	25	NMOD	0
25	healing	healing	I-NP	NN	O	23	PMOD	0
26	associated	associate	B-VP	VBN	O	25	NMOD	0
27	with	with	B-PP	IN	O	26	VMOD	0
28	radiation	radiation	B-NP	NN	O	29	NMOD	0
29	therapy	therapy	I-NP	NN	O	27	PMOD	0
30	.	.	O	.	O	17	P	0

1	We	We	B-NP	PRP	O	2	SUB	0
2	have	have	B-VP	VBP	O	0	ROOT	0
3	examined	examine	I-VP	VBN	O	2	VC	0
4	this	this	B-NP	DT	O	5	NMOD	0
5	hypothesis	hypothesis	I-NP	NN	O	3	OBJ	0
6	using	use	B-VP	VBG	O	5	NMOD	0
7	a	a	B-NP	DT	O	8	NMOD	0
8	model	model	I-NP	NN	O	6	OBJ	0
9	that	that	B-NP	WDT	O	8	NMOD	0
10	measures	measure	B-VP	VBZ	O	9	SBAR	0
11	the	the	B-NP	DT	O	12	NMOD	0
12	neovascularization	neovascularization	I-NP	NN	O	10	OBJ	3	neovascularization
13	of	of	B-PP	IN	O	12	NMOD	0
14	an	an	B-NP	DT	O	17	NMOD	0
15	implanted	implant	I-NP	VBN	O	17	NMOD	0
16	foreign	foreign	I-NP	JJ	O	17	NMOD	0
17	material	material	I-NP	NN	O	13	PMOD	0
18	.	.	O	.	O	2	P	0

1	Expanded	Expand	B-NP	VBN	O	2	NMOD	0
2	polytetrafluoroethylene	polytetrafluoroethylene	I-NP	NN	O	6	NMOD	0
3	(	(	O	(	O	5	DEP	0
4	PTFE	PTFE	B-NP	NN	O	5	DEP	0
5	)	)	O	)	O	2	NMOD	0
6	sheets	sheet	B-NP	NNS	O	7	SUB	0
7	were	be	B-VP	VBD	O	0	ROOT	0
8	implanted	implant	I-VP	VBN	O	7	VC	19	implanted
9	adjacent	adjacent	B-ADJP	JJ	O	8	VMOD	0
10	to	to	B-PP	TO	O	9	AMOD	0
11	both	both	O	CC	O	15	NMOD	0
12	superficial	superficial	B-NP	JJ	O	15	NMOD	0
13	epigastric	epigastric	I-NP	JJ	O	15	NMOD	0
14	vascular	vascular	I-NP	JJ	O	15	NMOD	0
15	pedicles	pedicle	I-NP	NNS	O	10	PMOD	0
16	of	of	B-PP	IN	O	15	NMOD	0
17	63	63	B-NP	CD	O	18	NMOD	0
18	rats	rat	I-NP	NNS	O	16	PMOD	0
19	distributed	distribute	B-VP	VBN	O	18	NMOD	0
20	into	into	B-PP	IN	O	19	VMOD	0
21	7	7	B-NP	CD	O	22	NMOD	0
22	groups	group	I-NP	NNS	O	20	PMOD	0
23	(	(	O	(	O	27	DEP	0
24	n	n	B-NP	NN	O	26	SUB	0
25	=	=	B-VP	SYM	O	26	VMOD	0
26	7	7	B-NP	CD	O	27	DEP	0
27	)	)	O	)	O	22	NMOD	0
28	that	that	B-NP	WDT	O	22	NMOD	0
29	differed	differ	B-VP	VBD	O	28	SBAR	0
30	with	with	B-PP	IN	O	29	VMOD	0
31	respect	respect	B-NP	NN	O	30	PMOD	0
32	to	to	B-PP	TO	O	31	NMOD	0
33	dose	dose	B-NP	NN	O	35	NMOD	0
34	and	and	I-NP	CC	O	35	NMOD	0
35	timing	timing	I-NP	NN	O	32	PMOD	0
36	of	of	B-PP	IN	O	35	NMOD	0
37	irradiation	irradiation	B-NP	NN	O	36	PMOD	0
38	.	.	O	.	O	7	P	0

1	Zero	Zero	B-NP	NN	O	14	SUB	0
2	to	to	B-PP	TO	O	1	NMOD	0
3	10	10	B-NP	CD	O	5	NMOD	0
4	daily	daily	I-NP	JJ	O	5	NMOD	0
5	fractions	fraction	I-NP	NNS	O	2	PMOD	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	electron-beam	electron-beam	B-NP	NN	O	8	NMOD	0
8	radiation	radiation	I-NP	NN	O	6	PMOD	0
9	(	(	O	(	O	13	DEP	0
10	300	300	B-NP	CD	O	11	NMOD	0
11	cGy	cGy	I-NP	NN	O	13	DEP	0
12	each	each	B-NP	DT	O	11	NMOD	0
13	)	)	O	)	O	8	NMOD	0
14	were	be	B-VP	VBD	O	0	ROOT	0
15	delivered	deliver	I-VP	VBN	O	14	VC	0
16	to	to	B-PP	TO	O	15	VMOD	0
17	the	the	B-NP	DT	O	18	NMOD	0
18	implant	implant	I-NP	NN	O	16	PMOD	0
19	in	in	B-PP	IN	O	18	NMOD	0
20	the	the	B-NP	DT	O	22	NMOD	0
21	right	right	I-NP	JJ	O	22	NMOD	0
22	groin	groin	I-NP	NN	O	19	PMOD	0
23	,	,	O	,	O	14	P	0
24	while	while	B-SBAR	IN	O	14	VMOD	0
25	the	the	B-NP	DT	O	26	NMOD	0
26	implant	implant	I-NP	NN	O	31	SUB	0
27	in	in	B-PP	IN	O	26	NMOD	0
28	the	the	B-NP	DT	O	30	NMOD	0
29	left	left	I-NP	JJ	O	30	NMOD	0
30	groin	groin	I-NP	NN	O	27	PMOD	0
31	served	serve	B-VP	VBD	O	24	SBAR	0
32	as	as	B-PP	IN	O	31	VMOD	0
33	a	a	B-NP	DT	O	36	NMOD	0
34	nonirradiated	nonirradiated	I-NP	JJ	O	36	NMOD	0
35	internal	internal	I-NP	JJ	O	36	NMOD	0
36	control	control	I-NP	NN	O	32	PMOD	0
37	.	.	O	.	O	14	P	0

1	Unirradiated	Unirradiated	B-NP	JJ	O	2	NMOD	0
2	animals	animal	I-NP	NNS	O	3	SUB	0
3	showed	show	B-VP	VBD	O	0	ROOT	0
4	equal	equal	B-NP	JJ	O	5	NMOD	0
5	neovascularization	neovascularization	I-NP	NN	O	3	OBJ	3	neovascularization
6	of	of	B-PP	IN	O	5	NMOD	0
7	both	both	B-NP	DT	O	8	NMOD	0
8	implants	implant	I-NP	NNS	O	6	PMOD	0
9	.	.	O	.	O	3	P	0

1	Rats	Rat	B-NP	NNS	O	17	SUB	0
2	that	that	B-NP	WDT	O	1	NMOD	0
3	were	be	B-VP	VBD	O	2	SBAR	0
4	irradiated	irradiate	I-VP	VBN	O	3	VC	19	irradiated
5	twice	twice	B-ADVP	RB	O	4	VMOD	0
6	(	(	O	(	O	16	DEP	0
7	single	single	B-NP	JJ	O	8	NMOD	0
8	fractions	fraction	I-NP	NNS	O	16	DEP	0
9	at	at	B-PP	IN	O	8	NMOD	0
10	0	0	B-NP	CD	O	12	AMOD	0
11	and	and	I-NP	CC	O	12	AMOD	0
12	24	24	I-NP	CD	O	13	NMOD	0
13	hours	hour	I-NP	NNS	O	9	PMOD	0
14	after	after	B-PP	IN	O	8	NMOD	0
15	implantation	implantation	B-NP	NN	O	14	PMOD	0
16	)	)	O	)	O	5	AMOD	0
17	did	do	B-VP	VBD	O	0	ROOT	0
18	not	not	I-VP	RB	O	17	VMOD	0
19	show	show	I-VP	VB	O	17	VC	0
20	a	a	B-NP	DT	O	22	NMOD	0
21	significant	significant	I-NP	JJ	O	22	NMOD	0
22	decrease	decrease	I-NP	NN	O	19	OBJ	18	decrease
23	in	in	B-PP	IN	O	22	NMOD	0
24	the	the	B-NP	DT	O	25	NMOD	0
25	neovascularization	neovascularization	I-NP	NN	O	23	PMOD	3	neovascularization
26	of	of	B-PP	IN	O	25	NMOD	0
27	the	the	B-NP	DT	O	29	NMOD	0
28	irradiated	irradiated	I-NP	JJ	O	29	NMOD	0
29	implant	implant	I-NP	NN	O	26	PMOD	0
30	compared	compare	B-PP	VBN	O	19	VMOD	0
31	with	with	B-PP	IN	O	30	PMOD	0
32	the	the	B-NP	DT	O	35	NMOD	0
33	contralateral	contralateral	I-NP	JJ	O	35	NMOD	0
34	control	control	I-NP	NN	O	35	NMOD	0
35	implant	implant	I-NP	NN	O	31	PMOD	0
36	.	.	O	.	O	17	P	0

1	In	In	B-PP	IN	O	25	VMOD	0
2	contrast	contrast	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	25	P	0
4	the	the	B-NP	DT	O	5	NMOD	0
5	implants	implant	I-NP	NNS	O	25	SUB	0
6	that	that	B-NP	WDT	O	5	NMOD	0
7	were	be	B-VP	VBD	O	6	SBAR	0
8	irradiated	irradiate	I-VP	VBN	O	10	NMOD	0
9	three	three	B-NP	CD	O	10	NMOD	0
10	times	time	I-NP	NNS	O	7	PRD	0
11	(	(	O	(	O	24	DEP	0
12	single	single	B-NP	JJ	O	13	NMOD	0
13	fractions	fraction	I-NP	NNS	O	24	DEP	0
14	at	at	B-PP	IN	O	13	NMOD	0
15	0	0	B-NP	CD	O	21	NMOD	0
16	,	,	I-NP	,	O	21	P	0
17	24	24	I-NP	CD	O	21	NMOD	0
18	,	,	O	,	O	21	P	0
19	and	and	O	CC	O	21	NMOD	0
20	48	48	B-NP	CD	O	21	NMOD	0
21	hours	hour	I-NP	NNS	O	14	PMOD	0
22	after	after	B-PP	IN	O	13	NMOD	0
23	implantation	implantation	B-NP	NN	O	22	PMOD	0
24	)	)	O	)	O	10	NMOD	0
25	demonstrated	demonstrate	B-VP	VBD	O	44	VMOD	0
26	significantly	significantly	I-VP	RB	O	25	VMOD	0
27	diminished	diminish	I-VP	VBN	O	25	VMOD	18	diminished
28	(	(	O	(	O	38	DEP	0
29	greater	great	B-NP	JJR	O	30	AMOD	0
30	than	than	I-NP	IN	O	32	NMOD	0
31	25	25	I-NP	CD	O	30	AMOD	0
32	percent	percent	I-NP	NN	O	34	NMOD	0
33	,	,	O	,	O	34	P	0
34	p	p	B-NP	NN	O	36	SUB	0
35	less	less	B-ADJP	JJR	O	36	AMOD	0
36	than	than	B-PP	IN	O	38	DEP	0
37	0.05	0.05	B-NP	CD	O	36	AMOD	0
38	)	)	O	)	O	39	NMOD	0
39	neovascularization	neovascularization	B-NP	NN	O	27	OBJ	3	neovascularization
40	beyond	beyond	B-PP	IN	O	39	NMOD	0
41	day	day	B-NP	NN	O	40	PMOD	0
42	7	7	I-NP	CD	O	41	NMOD	0
43	,	,	O	,	O	44	P	0
44	whereas	whereas	O	IN	O	0	ROOT	0
45	implants	implant	B-NP	NNS	O	46	SUB	0
46	irradiated	irradiate	B-VP	VBD	O	44	VMOD	0
47	only	only	B-ADVP	RB	O	48	PMOD	0
48	at	at	B-PP	IN	O	46	VMOD	0
49	48	48	B-NP	CD	O	50	NMOD	0
50	hours	hour	I-NP	NNS	O	48	PMOD	0
51	after	after	B-PP	IN	O	46	VMOD	0
52	implantation	implantation	B-NP	NN	O	53	SUB	0
53	did	do	B-VP	VBD	O	51	SBAR	0
54	not	not	O	RB	O	53	VMOD	0
55	.	.	O	.	O	44	P	0

1	Interestingly	Interestingly	B-ADVP	RB	O	7	VMOD	0
2	,	,	O	,	O	7	P	0
3	neovascularization	neovascularization	B-NP	NN	O	7	SUB	3	neovascularization
4	of	of	B-PP	IN	O	3	NMOD	0
5	the	the	B-NP	DT	O	6	NMOD	0
6	implants	implant	I-NP	NNS	O	4	PMOD	0
7	irradiated	irradiate	B-VP	VBD	O	0	ROOT	0
8	with	with	B-PP	IN	O	7	VMOD	0
9	10	10	B-NP	CD	O	10	NMOD	0
10	fractions	fraction	I-NP	NNS	O	8	PMOD	0
11	(	(	O	(	O	14	DEP	0
12	3000	3000	B-NP	CD	O	13	NMOD	0
13	cGy	cGy	I-NP	NN	O	14	DEP	0
14	)	)	O	)	O	10	NMOD	0
15	was	be	B-VP	VBD	O	7	VMOD	0
16	not	not	I-VP	RB	O	15	VMOD	0
17	significantly	significantly	I-VP	RB	O	15	VMOD	0
18	decreased	decrease	I-VP	VBD	O	15	VMOD	18	decreased
19	compared	compare	B-PP	VBN	O	18	VMOD	0
20	with	with	B-PP	IN	O	19	PMOD	0
21	irradiation	irradiation	B-NP	NN	O	20	PMOD	0
22	with	with	B-PP	IN	O	21	NMOD	0
23	three	three	B-NP	CD	O	24	NMOD	0
24	fractions	fraction	I-NP	NNS	O	22	PMOD	0
25	(	(	O	(	O	28	DEP	0
26	900	900	B-NP	CD	O	27	NMOD	0
27	cGy	cGy	I-NP	NN	O	28	DEP	0
28	)	)	O	)	O	24	NMOD	0
29	.	.	O	.	O	7	P	0

1	Irradiation	Irradiation	B-NP	NN	O	9	SUB	0
2	delivered	deliver	B-VP	VBN	O	1	NMOD	0
3	before	before	B-PP	IN	O	2	VMOD	0
4	implantation	implantation	B-NP	NN	O	3	PMOD	0
5	(	(	O	(	O	8	DEP	0
6	900	900	B-NP	CD	O	7	NMOD	0
7	cGy	cGy	I-NP	NN	O	8	DEP	0
8	)	)	O	)	O	4	NMOD	0
9	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
10	neovascularization	neovascularization	B-NP	NN	O	9	OBJ	3	neovascularization
11	significantly	significantly	B-ADJP	RB	O	12	AMOD	0
12	less	less	I-ADJP	JJR	O	9	VMOD	0
13	than	than	B-PP	IN	O	12	AMOD	0
14	the	the	B-NP	DT	O	16	NMOD	0
15	same	same	I-NP	JJ	O	16	NMOD	0
16	dose	dose	I-NP	NN	O	13	PMOD	0
17	administered	administer	B-VP	VBN	O	16	NMOD	0
18	after	after	B-PP	IN	O	17	VMOD	0
19	implantation	implantation	B-NP	NN	O	18	PMOD	0
20	.	.	O	.	O	9	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	results	result	I-NP	NNS	O	6	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	this	this	B-NP	DT	O	5	NMOD	0
5	study	study	I-NP	NN	O	3	PMOD	0
6	suggest	suggest	B-VP	VBP	O	0	ROOT	0
7	that	that	B-SBAR	IN	O	6	VMOD	0
8	a	a	B-NP	DT	O	11	NMOD	0
9	subclinical	subclinical	I-NP	JJ	O	11	NMOD	0
10	cumulative	cumulative	I-NP	JJ	O	11	NMOD	0
11	dose	dose	I-NP	NN	O	15	SUB	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	900	900	B-NP	CD	O	14	NMOD	0
14	cGy	cGy	I-NP	NN	O	12	PMOD	0
15	is	be	B-VP	VBZ	O	7	SBAR	0
16	the	the	B-NP	DT	O	17	NMOD	0
17	threshold	threshold	I-NP	NN	O	15	PRD	0
18	for	for	B-PP	IN	O	17	NMOD	0
19	impaired	impaired	B-NP	JJ	O	21	NMOD	18	impaired
20	tissue	tissue	I-NP	NN	O	21	NMOD	0
21	revascularization	revascularization	I-NP	NN	O	18	PMOD	3	revascularization
22	provided	provide	B-VP	VBD	O	7	DEP	0
23	that	that	B-SBAR	IN	O	22	VMOD	0
24	treatment	treatment	B-NP	NN	O	25	SUB	0
25	is	be	B-VP	VBZ	O	23	SBAR	0
26	delivered	deliver	I-VP	VBN	O	25	VC	0
27	immediately	immediately	B-ADVP	RB	O	26	VMOD	0
28	after	after	B-PP	IN	O	26	VMOD	0
29	implantation	implantation	B-NP	NN	O	28	PMOD	0
30	over	over	B-PP	IN	O	26	VMOD	0
31	a	a	B-NP	DT	O	33	NMOD	0
32	48-hour	48-hour	I-NP	JJ	O	33	NMOD	0
33	interval	interval	I-NP	NN	O	30	PMOD	0
34	.	.	O	.	O	6	P	0

